NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Profit After Tax History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit After Tax | ₹1,388 Cr | ₹715 Cr | ₹170 Cr | ₹442 Cr | ₹458 Cr |
What is the latest Profit After Tax of NATCO PHARMA ?
Year | Profit After Tax |
---|---|
Mar2024 | ₹1,388 Cr |
Mar2023 | ₹715 Cr |
Mar2022 | ₹170 Cr |
Mar2021 | ₹442 Cr |
Mar2020 | ₹458 Cr |
How is Profit After Tax of NATCO PHARMA Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹1,388 Cr | 94.09 | |
Mar2023 | ₹715 Cr | 320.76 | |
Mar2022 | ₹170 Cr | -61.57 | |
Mar2021 | ₹442 Cr | -3.43 | |
Mar2020 | ₹458 Cr | - |
Compare Profit After Tax of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹14,808.9 Cr | 10.7% | 5.9% | -15.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 6% | 4% | 9.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 4.7% | 0.3% | 52.4% | Stock Analytics | |
CIPLA | ₹122,390.0 Cr | 7% | 3.7% | 7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | 4.1% | 6.4% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 6.3% | 5% | -4.7% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 10.7% |
5.9% |
-15.1% |
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses